Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Aug;46(8):809-811.
doi: 10.1007/s40264-023-01310-7. Epub 2023 May 27.

Comment on "Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project"

Jürgen O Kirchner  1
Affiliations
Comment

Comment on "Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project"

Jürgen O Kirchner. Drug Saf. 2023 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declares he has no conflict of interests

Comment in

Comment on

References

    1. Willame C, Dodd C, van der Aa L, Picelli G, Emborg HD, Kahlert J, Gini R, Huerta C, Martín-Merino E, McGee C, de Lusignan S, Roberto G, Villa M, Weibel D, Titievsky L, Sturkenboom MCJM. Incidence rates of autoimmune diseases in european healthcare databases: a contribution of the ADVANCE Project. Drug Saf. 2021;44(3):383–395. doi: 10.1007/s40264-020-01031-1. - DOI - PMC - PubMed
    1. Mahaux O, Bauchau V, Van Holle L. Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines. Pharmacoepidemiol Drug Saf. 2016;25(2):215–222. doi: 10.1002/pds.3918. - DOI - PMC - PubMed
    1. Gini R, Sturkenboom MCJ, Sultana J, Cave A, Landi A, Pacurariu A, Roberto G, Schink T, Candore G, Slattery J, Trifirò G, Working Group 3 of ENCePP (Inventory of EU data sources and methodological approaches for multisource studies) Different strategies to execute multi-database studies for medicines surveillance in real-world setting: a reflection on the European model. Clin Pharmacol Ther. 2020;108(2):228–235. doi: 10.1002/cpt.1833. - DOI - PMC - PubMed
    1. Willame C, Dodd C, Durán CE, Elbers R, Gini R, Bartolini C, Paoletti O, Wang L, Ehrenstein V, Kahlert J, Haug U, Schink T, Diez-Domingo J, Mira-Iglesias A, Carreras JJ, Vergara-Hernández C, Giaquinto C, Barbieri E, Stona L, Huerta C, Martín-Pérez M, García-Poza P, de Burgos A, Martínez-González M, Bryant V, Villalobos F, Pallejà-Millán M, Aragón M, Carreras JJ, Souverein P, Thurin NH, Weibel D, Klungel OH, Sturkenboom M. Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases—an ACCESS cohort study. Vaccine. 2023;41(1):251–262. doi: 10.1016/j.vaccine.2022.11.031. - DOI - PMC - PubMed
    1. Law B. (Brighton Collaboration), Acute Disseminated Encephalomyelitis (ADEM): Case Definition Companion Guide, SPEAC SO2- D2.5.2.1 - AESI Case Definition Companion Guide for 1st Tier AESI, 2021 Mar 5, page 10 - 12 (references page 7);https://brightoncollaboration.us/acute-disseminated-encephalomyelitis-ad.... Accessed 7 Jan 2023.